EW vs PALI · P/E 47, rev $1.39B vs P/E 15, $316.3M cap
Edwards Lifesciences Corp (EW) versus Palisade Bio Inc (PALI) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Palisade Bio Inc (PALI) is a biotechnology company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported PALI revenue for 2024-12-31 was $0. Net income was -$14.4M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. PALI currently screens at market cap $316.3M and trailing P/E 15.2.
EW currently screens at market cap $49.91B and trailing P/E 46.9. PALI currently screens at market cap $316.3M and trailing P/E 15.2.
Not investment advice. Open the EW and PALI stock pages for the full models.
Not investment advice.